• Whole Foods Market, Inc.'s WFM shares advanced 2.2% after the company reported second-quarter 2017 revenues of $3,737 million, beating the Zacks Consensus Estimate of $3,725 million
• Shares of Valeant Pharmaceuticals International, Inc. VRX advanced 8.8% following news of positive developments in a patent litigation case over the company's biggest drug, Xifaxan
• Symantec Corporation's SYMC shares fell 5.1% after the company reported fourth-quarter 2017 revenues of $1.115 billion, missing the Zacks Consensus Estimate of $1.165 billion
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.